Dr. Freter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Hospital Dr
Columbia, MO 65212Phone+1 573-882-8445Fax+1 573-884-5318
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1984 - 1987
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1981 - 1984
Washington University in St. Louis School of MedicineClass of 1981
Certifications & Licensure
CA State Medical License 1982 - Present
MO State Medical License 2006 - 2025
WA State Medical License Active through 2012
DC State Medical License 1989 - 2000
MD State Medical License 1985 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Modular EHR, Cerner Corporation, 2013
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
- Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia Start of enrollment: 2012 Dec 13
- Join now to see all
Publications & Presentations
PubMed
- Ehrlichia-Induced Hemophagocytic Lymphohistiocytosis (HLH) With No Response to Doxycycline Treatment.Hana Qasim, Ammar Al-Obaidi, Abat Khan, Carl Freter
Cureus. 2023-07-01 - 15 citationsMyeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.Nickolas Steinauer, Chun Guo, Chunfa Huang, Madeline Wong, Yifan Tu
Blood Advances. 2019-05-14 - 5 citationsOolong Tea Extract Induces DNA Damage and Cleavage and Inhibits Breast Cancer Cell Growth and Tumorigenesis.Haihong Shi, Jin Liu, Yifan Tu, Carl E. Freter, Chunfa Huang
Anticancer Research. 2018-11-01
Press Mentions
Wash U, SLU Line up with Biden’s ‘Cancer Moonshot’January 22nd, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
